Tag: BioMed X Institute
New Immuno-Oncology Research Project in Partnership With Merck Starts at the...
The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who can...
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against...
Researchers at the BioMed X Institute and the Universit?tsmedizin Mannheim just published the results of their collaboration around a new...
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer...
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer...
BioMed X Launches a New Call for Application in Autoimmune Disease...
A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune...
BioMed X and AbbVie Start New Research Project in the USA
BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in...
BioMed X Institute Starts Its First Research Project With Sanofi on...
Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim...
BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research:...
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities...
After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore...
